Ab-miR-NPs increased the sensitivity of sorafenib-resistant HCC by interfering with the expression of IGF1R and inhibiting the activity of Ras/Raf and PI3K/Akt signaling pathways associated with cell resistance [227]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.